NasdaqGS - Nasdaq Real Time Price USD

Amedisys, Inc. (AMED)

Compare
96.63 -0.53 (-0.55%)
At close: September 27 at 4:00 PM EDT
96.63 0.00 (0.00%)
After hours: September 27 at 4:02 PM EDT
Loading Chart for AMED
DELL
  • Previous Close 97.16
  • Open 97.01
  • Bid 89.19 x 200
  • Ask 104.71 x 200
  • Day's Range 96.60 - 97.01
  • 52 Week Range 89.55 - 98.95
  • Volume 268,186
  • Avg. Volume 417,336
  • Market Cap (intraday) 3.164B
  • Beta (5Y Monthly) 0.78
  • PE Ratio (TTM) 34.39
  • EPS (TTM) 2.81
  • Earnings Date Oct 22, 2024 - Oct 28, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 97.78

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.

www.amedisys.com

19,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AMED

View More

Performance Overview: AMED

Trailing total returns as of 9/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

AMED
1.65%
S&P 500
20.30%

1-Year Return

AMED
2.95%
S&P 500
34.27%

3-Year Return

AMED
37.80%
S&P 500
28.79%

5-Year Return

AMED
25.29%
S&P 500
92.71%

Compare To: AMED

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AMED

View More

Valuation Measures

Annual
As of 9/27/2024
  • Market Cap

    3.16B

  • Enterprise Value

    3.49B

  • Trailing P/E

    34.39

  • Forward P/E

    19.34

  • PEG Ratio (5yr expected)

    1.30

  • Price/Sales (ttm)

    1.38

  • Price/Book (mrq)

    2.81

  • Enterprise Value/Revenue

    1.52

  • Enterprise Value/EBITDA

    14.88

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.02%

  • Return on Assets (ttm)

    6.38%

  • Return on Equity (ttm)

    8.20%

  • Revenue (ttm)

    2.29B

  • Net Income Avi to Common (ttm)

    91.98M

  • Diluted EPS (ttm)

    2.81

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    149.88M

  • Total Debt/Equity (mrq)

    40.26%

  • Levered Free Cash Flow (ttm)

    130.74M

Research Analysis: AMED

View More

Company Insights: AMED

Research Reports: AMED

View More

People Also Watch